Form 4: Aurinia Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Chief Commercial Officer Scott Michael Habig sold 17,777 shares of Aurinia Pharmaceuticals to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On March 6, 2024, Scott Michael Habig, Chief Commercial Officer of Aurinia Pharmaceuticals Inc., sold 17,777 shares of common stock.
• The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units granted on March 2, 2023.
• The shares were sold at a weighted average price of $5.6, with individual transactions ranging from $5.475 to $5.755.
• Following the transaction, Habig directly owns 474,587 shares of Aurinia Pharmaceuticals Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be routine, covering tax obligations, and doesn't necessarily indicate a change in the executive's long-term outlook for the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the context of tax obligations.

Key Dates